A detailed history of Bank Of America Corp transactions in Omeros Corp stock. As of the latest transaction made, Bank Of America Corp holds 123,714 shares of OMER stock, worth $545,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
123,714
Previous 109,987 12.48%
Holding current value
$545,578
Previous $379,000 32.45%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.04 - $4.23 $41,730 - $58,065
13,727 Added 12.48%
123,714 $502,000
Q1 2024

May 15, 2024

SELL
$2.88 - $4.89 $173,445 - $294,495
-60,224 Reduced 35.38%
109,987 $379,000
Q4 2023

Feb 14, 2024

BUY
$1.08 - $3.63 $64,871 - $218,039
60,066 Added 54.53%
170,211 $556,000
Q2 2023

Aug 14, 2023

BUY
$4.45 - $7.57 $94,566 - $160,870
21,251 Added 23.91%
110,145 $599,000
Q1 2023

May 12, 2023

SELL
$2.48 - $5.22 $435,158 - $915,937
-175,467 Reduced 66.37%
88,894 $413,000
Q4 2022

Feb 10, 2023

BUY
$1.75 - $3.96 $93,936 - $212,564
53,678 Added 25.48%
264,361 $597,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $525,303 - $1.27 Million
-170,001 Reduced 44.66%
210,683 $663,000
Q2 2022

Aug 12, 2022

BUY
$1.92 - $6.28 $357,164 - $1.17 Million
186,023 Added 95.56%
380,684 $1.05 Million
Q1 2022

May 16, 2022

SELL
$5.07 - $7.2 $660,468 - $937,944
-130,270 Reduced 40.09%
194,661 $1.17 Million
Q4 2021

Feb 08, 2022

BUY
$5.67 - $8.54 $968,776 - $1.46 Million
170,860 Added 110.9%
324,931 $2.09 Million
Q3 2021

Nov 15, 2021

BUY
$13.4 - $16.3 $469,053 - $570,565
35,004 Added 29.4%
154,071 $2.12 Million
Q2 2021

Sep 13, 2021

BUY
$14.81 - $19.13 $1.76 Million - $2.28 Million
119,067 New
119,067 $1.77 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $277M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.